trending Market Intelligence /marketintelligence/en/news-insights/trending/jYNxKNb5weXuKQgo3lvZvA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Express Scripts closes $3.6B eviCore deal

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Express Scripts closes $3.6B eviCore deal

Express Scripts Holding Co. completed its $3.6 billion acquisition of privately held eviCore healthcare.

The company expects the deal to be accretive to adjusted EPS in 2018, excluding transaction-related expenses and amortization of intangibles.

Express Scripts' financial advisers on this transaction are Lazard Frères & Co. LLC and TripleTree LLC, and its legal advisers are Skadden Arps Slate Meagher & Flom LLP and Holland & Knight LLP.

EviCore's financial advisers for the deal are J.P. Morgan and Morgan Stanley, and its legal advisers are Paul Weiss Rifkind Wharton & Garrison LLP and Epstein Becker & Green PC.